One of the key pieces of the long-touted Dorchester Bay City vision is suddenly up for grabs. The development team behind the project is shopping a 13.6-acre chunk of land on Morrissey Boulevard, signaling that the math on big, lab-heavy projects in Boston has shifted fast.
The site at 2 Morrissey Blvd., purchased by the Accordia and Ares Management venture in 2019, is being marketed as a fully permitted development opportunity that could host millions of square feet of offices, labs, and housing. City approvals for the broader Dorchester Bay City master plan still stand, but testing the market for this parcel shows how quickly once-hot plays can cool.
2 Morrissey Hits The Market
Accordia Partners has hired Newmark to market roughly 13.6 acres at 2 Morrissey Blvd., with offering materials describing a site that can support about 2.4 million square feet across eight buildings, according to The Boston Globe. The pitch casts the parcel as a potentially transformative mixed-use hub, and it notes that a future owner could lean more heavily into housing if that is where the demand lands.
How The Site Changed Hands
The five-building office campus at 2 Morrissey changed hands in 2019, when a joint venture of Accordia and Ares Management bought it for about $110 million, industry reports show, along with existing operating leases that made it easier to stage redevelopment over time, according to Commercial Property Executive. Keeping office income flowing while laying groundwork for major infrastructure and climate-resilience upgrades was a core feature of the original Dorchester Bay City pitch.
UMass Lease Still Worth Billions On Paper
Next door, Accordia controls the Bayside site under a 99-year ground lease with the UMass Building Authority, a deal the university said could generate between $192 million and $235 million depending on approvals, according to a university release from the UMass System. Accordia has maintained that it remains committed to the Bayside waterfront work even as it explores a sale of the Morrissey parcel, and the developers have already paid millions in fees and deposits tied to the long-term lease, The Boston Globe reported.
Market Headwinds Have Arrived
Local trade coverage points to a hefty oversupply of lab space, rising construction costs, and a tougher financing climate, all of which make large speculative, lab-focused projects far trickier to pull off right now, industry analysts told Banker & Tradesman. Developers have already trimmed parts of the Dorchester Bay City plan and reworked elements of the layout in response to both neighborhood feedback and market realities, according to Bisnow. Against that backdrop, testing buyer interest for a permitted Morrissey site starts to look less like a surprise move and more like risk management.
What Comes Next
Newmark will continue marketing the property while Accordia and Ares review offers. Any sale would leave existing city approvals for Dorchester Bay City in place, and significant changes to the plan would still have to go through the Boston Planning & Development Agency public review process, according to BPDA records.
For neighbors and local stakeholders, a sale could introduce a new developer into a project that is already a long-term play, or it could slow things down further if a buyer insists on different economics. Either way, 2 Morrissey is suddenly a live test of what the Boston market will support in this next, more cautious chapter.
